

‼️ BOMBSHELL‼️ Just 13 months ago the FDA approved GSK's 5-in-1 MenABCWY vaccine covering the exact deadly strains currently exploding in Kent, UK (heavy on MenB via Bexsero tech) for ages 10-25. Meanwhile, mRNA tech for meningococcal vaccines is quietly advancing in patents (e.g., Sanofi's hybrid proposals), building on COVID success. CONVENIENT TIMING... OR JUST ANOTHER "COINCIDENCE"? Funny how when outbreaks hit, the "solutions" are already patented and approved. Sources: Biopharm International February 19, 2025 biopharminternational.com/view/fda-appro… The patent landscape of Meningococcal Vaccine Synapse by Patsnap 17 March 2025 synapse.patsnap.com/article/the-pa… PLEASE REPOST AND HELP EXPOSE THIS! @ABridgen @JacquiDeevoy1 @RWMaloneMD @TruthAsylum121 @CartlandDavid


























